This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: 2020 Genesystems Inc., Panacea Pharmaceuticals, Inc.. Active years: 2004-2023.
Company Filing History:
Years Active: 2004-2023
Title: The Innovative Contributions of Michael Lebowitz
Introduction
Michael Lebowitz is a notable inventor based in Baltimore, MD, who has made significant contributions to the field of cancer detection. With a total of six patents to his name, his work focuses on developing methods and algorithms that enhance the accuracy of cancer diagnostics. His innovative approaches have the potential to transform how cancer risk is assessed in patients.
Latest Patents
Among his latest patents, Lebowitz has developed methods and algorithms for aiding in the detection of cancer. One of his key inventions describes a method of data interpretation from a multiplex cancer assay. This method involves transforming the aggregate normalized score from the assay into a quantitative risk score. This score quantifies a human subject's increased risk for the presence of cancer compared to the known prevalence of the cancer in the population before testing the subject. This innovative approach aims to provide more accurate assessments of cancer risk, ultimately improving patient outcomes.
Career Highlights
Throughout his career, Michael Lebowitz has worked with several prominent companies, including Panacea Pharmaceuticals, Inc. and 2020 Genesystems Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in cancer detection technologies.
Collaborations
Lebowitz has collaborated with notable professionals in his field, including Ronald Shore and Benjamin Wolozin. These collaborations have further enriched his research and development efforts, leading to innovative solutions in cancer diagnostics.
Conclusion
Michael Lebowitz's contributions to cancer detection through his patents and collaborations highlight his commitment to improving healthcare outcomes. His innovative methods and algorithms represent a significant advancement in the fight against cancer.